Drug name - Evoclin

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7374747 MYLAN Pharmaceutical foam Jan, 2024

(1 year, 3 months from now)

US7141237 MYLAN Pharmaceutical foam Feb, 2024

(1 year, 4 months from now)

Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient

Treatment: Treatment of acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
1% AEROSOL, FOAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.